A recent position paper from leading diabetes experts emphasizes the expanding role of continuous glucose monitoring (CGM) systems in managing Type 2 diabetes. CGMs facilitate real-time glucose tracking, improving glycemic control and informing treatment adjustments beyond traditional tests. Complementary studies including Pennington Biomedical’s endocrinology clinic launch and surveys on insulin and medication adherence underline the growing integration of technology-driven solutions across diabetes care landscapes, aiming to enhance patient outcomes and quality of life.